Real-world comparative effectiveness of tofacitinib, tumour necrosis factor inhibitors, and interleukin 17 inhibitors among patients with axial spondylarthritis and psoriatic arthritis

15/11/2024
29/07/2025
EU PAS number:
EUPAS1000000226
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

A3921446_Protocol_V1_23AUG2024_ REDACTED.pdf

English (1.1 MB - PDF) View document
Updated protocol

A3921446 Protocol_V3.0_10JULY2025_FINAL_Redacted.pdf

First published: 28/07/2025
English (916.27 KB - PDF) View document

A3921446 Protocol V 2.0 dated 03 JAN 2025_FINAL_Redacted.pdf

First published: 03/02/2025
English (886.66 KB - PDF) View document
Study results
Study report
Other information